Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug 19;105(33):11869-74.
doi: 10.1073/pnas.0804799105. Epub 2008 Jul 30.

DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

Affiliations

DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

Guillaume Lettre et al. Proc Natl Acad Sci U S A. .

Abstract

Sickle cell disease (SCD) is a debilitating monogenic blood disorder with a highly variable phenotype characterized by severe pain crises, acute clinical events, and early mortality. Interindividual variation in fetal hemoglobin (HbF) expression is a known and potentially heritable modifier of SCD severity. High HbF levels are correlated with reduced morbidity and mortality. Common single nucleotide polymorphisms (SNPs) at the BCL11A and HBS1L-MYB loci have been implicated previously in HbF level variation in nonanemic European populations. We recently demonstrated an association between a BCL11A SNP and HbF levels in one SCD cohort [Uda M, et al. (2008) Proc Natl Acad Sci USA 105:1620-1625]. Here, we genotyped additional BCL11A SNPs, HBS1L-MYB SNPs, and an SNP upstream of (G)gamma-globin (HBG2; the XmnI polymorphism), in two independent SCD cohorts: the African American Cooperative Study of Sickle Cell Disease (CSSCD) and an SCD cohort from Brazil. We studied the effect of these SNPs on HbF levels and on a measure of SCD-related morbidity (pain crisis rate). We strongly replicated the association between these SNPs and HbF level variation (in the CSSCD, P values range from 0.04 to 2 x 10(-42)). Together, common SNPs at the BCL11A, HBS1L-MYB, and beta-globin (HBB) loci account for >20% of the variation in HbF levels in SCD patients. We also have shown that HbF-associated SNPs associate with pain crisis rate in SCD patients. These results provide a clear example of inherited common sequence variants modifying the severity of a monogenic disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Distribution of fetal hemoglobin levels conditioned on SNP genotypes. For HBS1L-MYB rs9399137 and β-globin XmnI rs7482144, there are no individuals with the homozygote minor allele genotype. Boxes have lines at the lower quartile, median, and upper quartile. The plot whiskers extend up and down from the median a distance 1.5 times the interquartile range of the boxes (truncated at zero where necessary). Outliers are the points outside the whiskers indicated as circles.

Comment in

  • Genetic complexity in sickle cell disease.
    Higgs DR, Wood WG. Higgs DR, et al. Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11595-6. doi: 10.1073/pnas.0806633105. Epub 2008 Aug 11. Proc Natl Acad Sci U S A. 2008. PMID: 18695233 Free PMC article. No abstract available.

References

    1. Weatherall DJ, et al. Disease control priorities in developing countries. 2nd Ed. New York, NY: Oxford Univ Press; 2006. Inherited disorders of hemoglobin; pp. 663–680.
    1. Platt OS, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11–16. - PubMed
    1. Castro O, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood. 1994;84:643–649. - PubMed
    1. Platt OS, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–1644. - PubMed
    1. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762–769. - PubMed

Publication types

MeSH terms